Next Article in Journal
Autophagy in Premature Senescent Cells Is Activated via AMPK Pathway
Previous Article in Journal
Arsenic and Antimony Transporters in Eukaryotes
Int. J. Mol. Sci. 2012, 13(3), 3549-3562; doi:10.3390/ijms13033549
Article

A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli

1
,
2
,
3
 and
2,3,*
1 Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala-Lumpur, Malaysia 2 Institute of Biological Science, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia 3 Center for Research in Biotechnology for Agriculture (CEBAR), University Malaya, 50603, Kuala-Lumpur, Malaysia
* Author to whom correspondence should be addressed.
Received: 4 January 2012 / Revised: 28 February 2012 / Accepted: 6 March 2012 / Published: 15 March 2012
View Full-Text   |   Download PDF [429 KB, 19 June 2014; original version 19 June 2014]   |   Browse Figures

Abstract

Adiponectin is one of the most bioactive substances secreted by adipose tissue and is involved in the protection against metabolic syndrome, artherosclerosis and type II diabetes. Research into the use of adiponectin as a promising drug for metabolic syndromes requires production of this hormone in high quantities considering its molecular isoforms. The objective of this study is to produce recombinant human adiponectin by Pichia pastoris (P-ADP) as a cheap and convenient eukaryotic expression system for potential application in pharmaceutical therapy. For comparison, adiponectin was also expressed using the Escherichia coli (E-ADP) expression system. Adiponectin was constructed by overlap-extension PCR, and cloned in standard cloning vector and hosts. Recombinant expression vectors were cloned in the P. pastoris and E. coli host strains, respectively. SDS-PAGE and western blotting were used to detect and analyse expressed recombinant protein in both systems. Adiponectin was purified by affinity chromatography and quantified using the Bradford Assay. The results of this study indicated that P-ADP quantity (0.111 mg/mL) was higher than that of E-ADP (0.04 mg/mL) and both were produced in soluble form. However, P-ADP was able to form high molecular weights of adiponectin molecules, whilst E-ADP was not able to form isoforms higher than trimer. In addition, P-ADP was more active in lowering blood glucose compared with E-ADP. The two types of proteins were equally efficient and significantly decreased blood triglyceride and increased high density lipoprotein. We conclude that P. pastoris is able to produce high quantity of bioactive adiponectin for potential use in treatment of metabolic syndromes.
Keywords: adiponectin; Pichia pastoris; E.coli; recombinant protein; biological activity adiponectin; Pichia pastoris; E.coli; recombinant protein; biological activity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Rothan, H.A.; Teh, S.H.; Haron, K.; Mohamed, Z. A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli . Int. J. Mol. Sci. 2012, 13, 3549-3562.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert